PFE stock profile - insider summary

Manage Columns

Name
Date
Title
Total Bought
Total Sold
Updated
IssuerCik
SubKey
netTransacted

Name
Date
Title
Total Bought
Total Sold
Updated
IssuerCik
SubKey
netTransacted

DAMICO JENNIFER B.

2023/05/20

SVP & Controller

137024

-47209

2023-05-20

0000078003

0000078003

89815
RINGO WILLIAM R

2023/05/19

Senior Vice President

399255

2023-05-19

0000078003

0000078003

399255
RINGO WILLIAM R

2023/05/18

Senior Vice President

399255

2023-05-18

0000078003

0000078003

399255
RINGO WILLIAM R

2023/05/17

Senior Vice President

399255

2023-05-17

0000078003

0000078003

399255
DAMELIO FRANK A

2023/05/16

Senior Vice President

1459672

-122380

2023-05-16

0000078003

0000078003

1337292
DAMELIO FRANK A

2023/05/15

Senior Vice President

1459672

-122380

2023-05-15

0000078003

0000078003

1337292
RINGO WILLIAM R

2023/05/14

Senior Vice President

399255

2023-05-14

0000078003

0000078003

399255
RINGO WILLIAM R

2023/05/13

Senior Vice President

399255

2023-05-13

0000078003

0000078003

399255
SUSMAN SALLY

2023/05/12

Executive Vice President

5457221

-1988607

2023-05-12

0000078003

0000078003

3468614
Fonseca Lidia

2023/05/11

Executive Vice President

571083

-25515

2023-05-11

0000078003

0000078003

545568

1 2 3 4 5 6 7 8 9 10

PFE stock profile - insider summary

Related News

Netflix (NASDAQ:NFLX) Rockets with Bold Moves into Live Sports and Ads: Can Growth Sustain?

NASDAQ:DJT’s Explosive Election-Fueled Rally – Stock Jumps 18% Amidst Wild Market Swings!

Globalstar (NYSE: GSAT) – Apple Partnership, Revenue Growth, and the Path to Profitability

Vita Coco (NASDAQ:COCO): Strong Q3 Results, Growing Market Position, and Institutional Backing

Bitcoin’s Next Bull Run: Why Analysts Are Eyeing New Highs - NASDAQ:COIN & NASDAQ:MSTR Momentum

Nvidia (NASDAQ: NVDA): Leading AI Innovation and Capitalizing on Explosive Data Center Growth

News on the web

BNTX Earnings: BioNTech Reports Better-than-Expected Q3 Earnings, Lowers Revenue Outlook

Is Moderna (NASDAQ:MRNA) Stock a Buy at Current Levels?

PFE Earnings: Pfizer Blows Past Estimates in Q2

Down 60% in 3 Years, Will Moderna Stock (NASDAQ:MRNA) Fall Further?

Pfizer Sets Sight on Obesity Market with Weight Loss Pill

Pfizer (NYSE:PFE) Trends Higher on Mixed Q4 Print

Options Volatility and Implied Earnings Moves Today, January 30, 2024

M & A News: Suave Brands Acquires Haleon’s (NYSE:HLN) ChapStick in $510M Deal

GLP-1 Anti-Obesity Drugs: Slim Waistlines, Fat Profits

Ex-Dividend Date Nearing for These 10 Stocks – Week of January 22, 2024

M & A News: GSK (NYSE:GSK) Offloads Partial Stake in Haleon for $1.2B

M & A News: Pfizer (NYSE:PFE) to Seal $43B Seagen Deal, Analyst Remains Upbeat

Goldman Sachs Says These 3 Healthcare Giants Look Very Attractive Right Now

Pfizer (NYSE:PFE) Little Changed as White House Pursues Drug Patents

Pfizer (NYSE:PFE) Slides as Weight Loss Drug Suffers Setback

Biden Plans to Boost Drug Production Using Cold-War Era Law

Pfizer (NYSE:PFE) Sued Re:Low-Quality ADHD Drug for Kids

Pfizer (NYSE:PFE) to Layoff 500 Workers at UK Site

Ex-Dividend Date Nearing for These 10 Stocks – Week of November 6-10, 2023

Pfizer (NYSE:PFE) Delivers Lackluster Q3

Mixed Day for Vaccine Stocks as Terrible News Emerges

Roivant (NASDAQ:ROIV) Gains after Roche’s $7.1 Billion Buy of Televant

Pfizer (NYSE:PFE) Dips as UBS Starts Coverage

Pfizer (NYSE:PFE) Slides despite EU Nod to Seagen Acquisition

Alphabet Stock (NASDAQ:GOOGL) Q3 Earnings Preview: Can Its Strength be Sustained?

LLY vs. PFE: Which Pharma Stock is the Better Buy?

Pfizer (NYSE:PFE) Slips on Drug Price Hikes

Pfizer (NYSE:PFE) Provides FTC with Documents for Seagen Acquisition

Moderna (NASDAQ:MRNA) Slides as COVID-19 Vaccine Sales Confirmed

Pfizer Stock (NYSE:PFE) Down; Waning COVID Sales Hit Guidance

Novavax (NASDAQ:NVAX): Europe Delays Vaccine Approval

BioNTech (NASDAQ: BNTX) Slides After $0.9 Billion Comirnaty Write-Off

Pfizer (NYSE:PFE) Bags Approval for 2 Drugs

Pfizer (NYSE:PFE) Down despite Hefty Number of COVID-19 Shots

Drug Companies Mixed as Medicare Plans to Negotiate

Novavax (NASDAQ:NVAX) Surges Following Success Against COVID-19 Variants

Will BioNTech’s (NASDAQ:BNTX) COVID-19 Vaccine Sales Reaccelerate?

Moderna’s (NASDAQ:MRNA) Updated COVID Vaccine Effective Against Eris Variant